Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04017442 · ClinicalTrials.gov registry record · Phase 4
Neuraxial Preservative Free Morphine for Normal Spontaneous Vaginal Delivery
A Phase 4 study of Postpartum Depression and Postpartum Pain, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- Phase 4
- Development phase
- 160
- Enrollment target
- 1
- Study location
NCT04017442 is a Phase 4 study of Postpartum Depression and Postpartum Pain that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 160 participants, below the 530-participant average among 38 other Postpartum Depression trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04017442, a Phase 4 study of Postpartum Depression and Postpartum Pain, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 160 participants
- Enrollment target
- 1
- Study location
Study Summary
Patients presenting for normal spontaneous vaginal delivery who have a neuraxial anesthestic will be randomized to receive preservative free morphine or saline placebo after delivery.
Conditions Studied
Interventions
- DRUG Saline
- DRUG Preservative Free Morphine
Study Locations (1)
New York
- Mount Sinai Hospital - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2019-10-19 |
| Est. Completion | 2023-08-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04017442
The ClinicalTrials.gov registry entry for NCT04017442 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 530-participant average among 38 other Postpartum Depression trials with a reported enrollment target (70% lower). The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Postpartum Depression appearing as the primary indexed condition, and to 2 interventions - of which Saline is the first listed.
NCT04017442 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT04017442 about?
NCT04017442 is a clinical study titled "Neuraxial Preservative Free Morphine for Normal Spontaneous Vaginal Delivery". Patients presenting for normal spontaneous vaginal delivery who have a neuraxial anesthestic will be randomized to receive preservative free morphine or saline placebo after delivery.
What is the current status of trial NCT04017442?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 160 participants. The study started on 2019-10-19. Estimated completion is 2023-08-31.
What conditions does trial NCT04017442 study?
This clinical trial studies the following conditions: Postpartum Depression, Postpartum Pain, Opioid Consumption.
What interventions are being tested in trial NCT04017442?
The interventions under investigation include: Saline (DRUG), Preservative Free Morphine (DRUG).
Who is sponsoring clinical trial NCT04017442?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04017442 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postpartum Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study To Assess The Safe-Use Conditions For Administration of ZULRESSO® in a Home Setting
COMPLETED · Phase 4
-
Preventing Postpartum Depression in Immigrant Latinas
RECRUITING · NA
-
In-person vs. Virtual Delivery of a Group-based Prevention of Postpartum Depression
RECRUITING · NA
-
Postpartum Care in the NICU (PeliCaN) Transitions
RECRUITING · NA
-
Maternal Mental Health Access - MaMa
RECRUITING · NA
-
Ketamine Pharmacokinetics and Pharmacodynamics for Postpartum Depression and Pain After Cesarean Delivery
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.